EDGAR Filing Documents for 0001564590-17-005616

Form 8-K - Current report:

SEC Accession No. 0001564590-17-005616

Filing Date

2017-03-30

Accepted

2017-03-30 16:09:17

Documents

Period of Report

2017-03-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	BIOC-8K-20170330	bioc-8k_20170328.htm	8-K	51737
2	EX-4.1	bioc-ex41_16.htm	EX-4.1	104211
3	EX-5.1	bioc-ex51_15.htm	EX-5.1	13283
4	EX-10.1	bioc-ex101_14.htm	EX-10.1	234462
5	EX-10.2	bioc-ex102_13.htm	EX-10.2	178612
6	EX-10.3	bioc-ex103_11.htm	EX-10.3	22053
7	EX-99.1	bioc-ex991_12.htm	EX-99.1	13356
8	GRAPHIC	g2017033017524163254465.jpg	GRAPHIC	8892
9	GRAPHIC	g2017033017522458555442.jpg	GRAPHIC	7292
	Complete submission text file	0001564590-17-005616.txt		641506

Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121

Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200

BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)